MBMithun Mohanraor Bandivadeka

Mithun Mohanraor Bandivadeka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mithun Mohanraor Bandivadeka has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Amit Choudhari

    Interactive Research School for Health Affair, Bharati Vidhyapeeth University, Pune, Maharashtra, India

    2 shared publications
  • Ashwini Madgulkar

    Department of Pharmaceutics, AISSMS College of Pharmacy

    2 shared publications
  • Ruchika Kaul-Ghanekar

    Interactive Research School for Health Affair, Bharati Vidhyapeeth University, Pune, Maharashtra, India

    2 shared publications
  • Soumya Koppikar

    Interactive Research School for Health Affair, Bharati Vidhyapeeth University, Pune, Maharashtra, India

    2 shared publications
  • Ashwini R. Madgulkar

    B Department of Pharmaceutics , AISSMS College of Pharmacy , Pune , Maharashtra , India

    1 shared publication
  • Mangesh R. Bhalekar

    B Department of Pharmaceutics , AISSMS College of Pharmacy , Pune , Maharashtra , India

    1 shared publication

Latest Publications

  • Open Access

    Formulation and Evaluation of Darunavir Ethanolate Nanogel as Microbicide in Pre-Exposure Prophylaxis for HIV Infection

    by Mithun Bandivadekar, Ashwini Madgulkar, Syed Mubashir Rashid, Ranjitkumar Padakanti, Vedanti Godbole

    Background Anti-retroviral drugs are challenging formulation scientists due to their poor solubility problem. This criticality increases when the drug has to be delivered by a vaginal route where the availability of fluid to solubilize the drug is less.Purpose The Darunavir Ethanolate nano gel was prepared to aim to increase its solubility and improve the dissolution profile to be delivered in the vaginal route for prophylaxis treatment of HIV.Materials and Methods Phase solubility study of Darunavir Ethanolate: Hydroxypropyl-β-cyclodextrin was performed (simulated vaginal fluid). Inclusion complex formation was confirmed by FTIR studies. Nanogel was synthesized using the emulsion solvent evaporation method and evaluated for particle size, polydispersity index, zeta potential and entrapment efficiency. Solubility enhancement study of optimized batch in simulated vaginal fluid at different pH conditions was compared with pure drug.Results The phase solubility diagram showed the AL type of curve indicating 1:1 complex formation with a stability constant of 618.071 M-1. The formulated nanogel batch F8 with particle size 338.8 nm, PDI; 0.344, zeta potential; -40.3 mV and % entrapment efficiency; 93.52 was selected as the optimized batch. Nanogel showed a 40.9753, 56.9891 and 100.91-fold increase in drug solubility compared to the pure drug in simulated vaginal fluid at pH 3.5, 4.5 and 5.5 respectively. (%) Cumulative drug release of 83% at 22 hr, drug flux at 0.4421 µg/cm2/hr was observed. The best-fit model was the Korsmeyer-Peppas model followed by the Higuchi and the Zero-order models.Conclusion The formulated nano gel showed increasing solubility and dissolution profile of Darunavir Ethanolate to be administered in the vaginal cavity for prophylaxis treatment of HIV.


  • Design and development of SMEDDS for colon-specific drug delivery

    by Sudhir T. Bansode, Sanjay J. Kshirsagar, Ashwini R. Madgulkar, Mangesh R. Bhalekar, Mithun M. Bandivadekar

    Lipoidal systems have particularly shown potential for specific accumulation in areas with inflamed tissue increasing the selectivity of local drug delivery. Formulation and evaluation of self-microemulsifying drug delivery system (SMEDDS) for colon-specific drug delivery for effective treatment of colonic diseases. Ternary phase diagram was used to optimize level of oil, surfactant and co-surfactant to optimize SMEDDS and were evaluated for percent transmittance, emulsification time, in vitro release, myeloperoxidase (MPO) activity and intestinal accumulation. The spray dried SMEDDS were filled in capsules which were enteric coated with Eudragit S-100 at 10% weight gain to ensure SMEDDS delivery at colon. The spray dried SMEDDS were also evaluated for IR, DSC, XRD, SEM and stability study. In ternary phase diagram, Capmul MCM C8 and Capmul PG12 NF with surfactant (Tween 20) and co-surfactant (PG) in ratio 2:1 and 3:1, respectively, showed maximum emulsification area. These liquid SMEDDS show maximum transmittance, globule size of 90-30 nm. The spray-dried SMEDDS with diluents show good flow property. The units of MPO activity show lower level as compared to pure drug and control group, histopathology results supports better healing with SMEDDS. This was attributed to accumulation of SMEDDS in inflammatory area as compared to drug which was further proved by accumulation study. Enteric-coated capsule containing SMEDDS are able to deliver drug, specifically at the colonic region. Higher accumulation of lipoidal drug in inflammatory area and specific release of liposomes by enteric-coated capsules provide better option for the treatment of colonic disease.


  • Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole

    by Ashwini Madgulkar, Mithun Bandivadekar, Tanaji Shid, Shivani Rao

    Solid dispersion of poorly soluble BCS class II drug, clotrimazole, was prepared with the aim of enhancing its dissolution profile. Solid dispersions were prepared using various sugars as carriers at different weight ratio to drug-like d-mannitol, d-fructose, d-dextrose and d-maltose by fusion method. The solubility of plain clotrimazole in different percent of sugar solutions was measured. Also, its solubility in solid dispersion and their physical mixture were assessed. The dissolution of all the prepared SD tablets, direct compressed clotrimazole tablet and plain drug were tested using the U.S. Pharmacopeia convention (USP) apparatus II. The dissolution profiles were characterized by parameters like area under curve (AUC), mean residence time (MRT), mean dissolution time (MDT) and percent dissolution efficiency (% DE). The release kinetics study was performed using DD Solver TM software. The selected solid dispersions (SDs) were evaluated for antifungal activity. A 100% solution of mannitol showed 806-fold increases in solubility as compared with plain clotrimazole in water. It was observed that the dissolution profile of clotrimazole was improved by mannitol SD at drug to sugar ration of 1:3. The percent DE value for mannitol SD tablet was found to be 77.3516% as against plain drug and directly compressed tablet of clotrimazole at 50.9439% and 31.33%, respectively. Also the antifungal activity indicated by inhibition zone was found to be 54 mm indicating enhance activity against Candida albicans as compared with plain CTZ at 6.6 mm. Thus, it can be concluded that the sugar alcohol, that is, mannitol is a more promising hydrophilic carrier for solid dispersion preparation to improve the solubility and dissolution of poorly soluble drugs.


  • Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study

    by Mithun Bandivadekar, Shyamsundar Pancholi, Ruchika Kaul-Ghanekar, Amit Choudhari, Soumya Koppikar

    Single non-ionic surfactant based self-nanoemulsifying drug delivery system (SNEDDS) was formulated and characterised for poor water soluble drug, Atorvastatin calcium. Capmul MCM oil showing highest solubility for Atorvastatin calcium was selected as oil phase. Self-nanoemulsifying capacity of Cremophor RH 40, Cremophor EL, Tween 20, Tween 60, Tween 80 and Labrasol were tested for the selected oil. In vitro dissolution studies were performed and were characterized by t85% and dissolution efficiency (DE). Cytotoxicity of the formulations and permeation enhancement of the drug across caco-2 cell monolayer was assessed. Capmul MCM was found to be better nanoemulsified in decreasing order of Cremophor RH 40 > Cremophor EL > Tween 20 > Tween 60 > Tween 80. Values of droplet size (range 11–83 nm), polydispersity index (range 0.07–0.65); zeta potential (range −3.97 to −19.0) and cloud point (60–85°C) before and after drug loading proves the uniformity and stability of the formulations. SNEDDS formulated with Tween 20 surfactant showed enhanced dissolution with t85% and DE values at 10 min and 78.70, respectively. None of the formulation showed cytotoxicity at the concentration tested. Tween 20 based SNEDDS enhanced permeation of the drug as compared with pure drug across cell lines. It can be concluded that SNEDDS can be formulated by using single non-ionic surfactant system for enhance dissolution and absorption of poorly soluble drug, Atorvastatin calcium.


  • Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug

    by Mithun Mohanraor Bandivadeka, Shyam Sundar Pancholi, Ruchika Kaul-Ghanekar, Amit Choudhari, Soumya Koppikar

    The main purpose of this work is to formulate self-microemulsifying drug delivery system (SMEDDS) using smaller molecular oil with Atorvastatin calcium as a model drug. Solubility of the selected drug was accessed in oils and surfactants. Percent transmittance (%T) test study was performed to identify the efficient self-microemulsifying formulations. Those formulations which showed higher value for %T were evaluated for droplet size, polydispersity index, ζ potential, refractive index and cloud point measurement. Effect of drug loading on droplet size, increasing dilution in different media, thermodynamic stability and in vitro dissolution was performed to observe the performance of the selected formulation. Further cytotoxicity and permeation enhancement studies were carried out on Caco2 cell lines. Of all the oils accessed for drug solubility, Capmul MCM showed higher solubility capacity for Atorvastatin calcium. Capmul MCM was better microemulsified using combination of Tween 20 and Labrasol surfactant. Droplet size was as low as 86.93 nm with polydispersity index and ζ potential at 0.195 ± 0.011 and −7.27 ± 3.11 mV respectively. The selected undiluted formulation showed refractive index values ranging from 1.40 to 1.47 indicating the isotropicity of the formulation. The selected formulation was robust to dilution in different media and thermodynamically stable. Dissolution profile was enhanced for the selected drug as compared to marketed formulation with t85% and DE values at 10 min and 80.15 respectively. Also cytotoxicity measurement showed minimum effect with good permeation enhancing capacity. Thus our study demonstrates the use of smaller molecular oil (Capmul MCM) for developing self-microemulsifying drug delivery system for better in vitro and in vivo performance.